Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Human primary cell isolation and culture testing provides researchers with physiologically relevant in vitro models derived directly from patient tissues, blood, and body fluids. This technical article outlines the sample types, testing items, isolation methodologies, quality control procedures, and research applications of professional primary cell isolation and culture services, supporting drug discovery, precision oncology, and translational biomedical research.

Technical Overview

Primary cells are living cells isolated directly from human tissues or biological fluids and maintained under controlled in vitro conditions. Unlike immortalized cell lines, primary cells preserve the genetic background, donor-specific phenotype, and functional characteristics of the original tissue, making them highly valuable models for translational research, drug response evaluation, and disease mechanism studies.

Human primary cell isolation and culture testing integrates a coordinated workflow consisting of specimen receipt and assessment, tissue dissociation into single-cell suspensions, debris and dead cell removal, selective purification of target cell populations, optimization of culture conditions, and comprehensive quality control. Successful isolation depends on rapid sample processing, gentle enzymatic or mechanical dissociation, carefully selected growth media, and rigorous sterility management throughout the entire procedure.

Testing Samples

Tumor Tissue Specimens

Fresh surgical resections and biopsies from solid tumors, including lung, breast, colorectal, liver, gastric, ovarian, pancreatic, and renal carcinomas. Specimens are transported in sterile transport medium containing antibiotics at 2–8°C and should be processed within 24 hours of excision to maximize cell viability and isolation success.

Peripheral Blood and Bone Marrow

Anticoagulated peripheral blood collected in EDTA or heparin tubes for peripheral blood mononuclear cell (PBMC) isolation, and bone marrow aspirates for harvesting mesenchymal stem cells (MSCs) and hematopoietic progenitor cells.

Normal and Adjacent Tissues

Normal tissues or tumor-adjacent tissues, including skin, liver, kidney, lung, and gastrointestinal mucosa, used for isolating fibroblasts, epithelial cells, endothelial cells, and hepatocytes for comparative and toxicological studies.

Adipose Tissue, Umbilical Cord, and Placenta

These specimens serve as rich and ethically accessible sources of mesenchymal stem cells, which are widely used in regenerative medicine research, secretome studies, and cell therapy development.

Body Fluids

Ascites, pleural effusion, and cerebrospinal fluid samples from malignant effusion patients, providing tumor cells, tumor-infiltrating lymphocytes, and other clinically relevant cell populations.

Testing Items

  • Primary cell isolation and purification from diverse specimen types
  • Cell viability assessment using trypan blue exclusion or acridine orange/propidium iodide (AO/PI) fluorescence staining
  • Viable cell counting and yield determination
  • Cell purity and phenotype identification by flow cytometry and immunocytochemistry
  • Contamination screening for mycoplasma, bacteria, and fungi
  • Short tandem repeat (STR) DNA profiling for donor authentication
  • Cell expansion, growth kinetics, and population doubling analysis
  • Differentiation potential assays for stem and progenitor cells
  • Cryopreservation and post-thaw recovery evaluation

Testing Methods

Enzymatic Digestion

Tissues are minced into 1–2 mm fragments and digested with enzymes selected according to tissue composition, typically collagenase type I or IV, dispase, hyaluronidase, DNase I, or trypsin-EDTA. Digestion parameters such as enzyme concentration, temperature, and incubation time are optimized to maximize yield while preserving surface markers and cell functionality.

Mechanical Dissociation and Explant Culture

Manual mincing combined with gentle mechanical dissociation is applied for fragile tissues, while the explant outgrowth method allows target cells, particularly fibroblasts and tumor cells, to migrate from tissue fragments onto the culture surface over one to two weeks.

Density Gradient Centrifugation

Ficoll-Paque density gradient separation is used to isolate PBMCs from whole blood and bone marrow samples, followed by red blood cell lysis when required. This method efficiently removes granulocytes, erythrocytes, and dead cells from the target fraction.

Selective Culture and Immunomagnetic Purification

Differential adhesion, differential trypsinization, and serum-free selective media are employed to enrich target populations and suppress fibroblast overgrowth. For high-purity requirements, magnetic-activated cell sorting (MACS) or fluorescence-activated cell sorting (FACS) is applied using validated positive and negative selection markers.

Culture Maintenance and Quality Control

Isolated cells are cultured in optimized basal media supplemented with appropriate sera, growth factors, and antibiotics, and maintained at 37°C in a humidified incubator with 5% CO2. Morphology, confluence, and proliferation are monitored microscopically, and each established culture undergoes mycoplasma testing, STR authentication, and phenotype verification before release.

Applications

  • High-throughput drug screening and compound efficacy evaluation using patient-derived primary tumor cells
  • Precision oncology and personalized treatment response prediction
  • Immunology research, including tumor-infiltrating lymphocyte functional analysis
  • Drug toxicity and safety assessment on physiologically relevant human cells
  • Regenerative medicine and mesenchymal stem cell therapy development
  • Gene function studies, signaling pathway research, and CRISPR-based genome editing
  • Construction of organoid and three-dimensional cell culture models
  • Disease modeling for mechanistic and biomarker discovery studies

FAQ

What sample quantity is required for isolation?

For solid tumor tissue, a minimum of 100 mg is generally recommended, while 5–10 mL of peripheral blood is sufficient for PBMC isolation. Larger specimens typically improve cell yield and isolation success rate.

How should specimens be transported to the laboratory?

Solid tissues should be placed in sterile transport medium with antibiotics and shipped cold at 2–8°C, whereas blood samples can be shipped at ambient temperature. All specimens should be delivered within 24–48 hours of collection.

What is the typical turnaround time?

Initial isolation and viability reporting usually require 3–7 working days, while full establishment of a stable proliferating culture, including authentication and quality control, may take 2–4 weeks depending on cell type and growth rate.

How many passages can primary cells undergo?

Most primary cells undergo replicative senescence after 10–20 population doublings, although this varies considerably by cell type. Early-passage cells (P1–P5) are recommended for experiments requiring maximal physiological relevance.

What ethical and biosafety requirements apply?

All human specimens must be collected with documented informed consent and appropriate ethical approval. Testing is performed under Biosafety Level 2 conditions, and donor privacy and sample traceability are strictly maintained throughout the workflow.